Show simple item record

dc.contributor.authorMacfarlane, Gary J
dc.contributor.authorHollick, Rosemary J
dc.contributor.authorMorton, LaKrista
dc.contributor.authorHeddle, Maureen
dc.contributor.authorBachmair, Eva-Maria
dc.contributor.authorAnderson, R Stuart
dc.contributor.authorWhibley, Daniel
dc.contributor.authorKeenan, Karen Forrest
dc.contributor.authorMurchie, Peter
dc.contributor.authorStelfox, Kevin
dc.contributor.authorBeasley, Marcus J
dc.contributor.authorJones, Gareth T
dc.date.accessioned2021-10-12T12:19:01Z
dc.date.available2021-10-12T12:19:01Z
dc.date.issued2021-10
dc.identifier.citationMacfarlane , G J , Hollick , R J , Morton , L , Heddle , M , Bachmair , E-M , Anderson , R S , Whibley , D , Keenan , K F , Murchie , P , Stelfox , K , Beasley , M J & Jones , G T 2021 , ' The effect of COVID19 public health restrictions on the health of people with musculoskeletal conditions and symptoms : the CONTAIN study ' , Rheumatology , vol. 60 , no. SI , pp. SI13-SI24 . https://doi.org/10.1093/rheumatology/keab374en
dc.identifier.issn1462-0324
dc.identifier.otherPURE: 191941328
dc.identifier.otherPURE UUID: 5884708d-821a-4650-9b0c-3ea724db0192
dc.identifier.otherPubMed: 34009314
dc.identifier.otherPubMed: 34009314
dc.identifier.otherORCID: /0000-0003-2322-3314/work/96652567
dc.identifier.otherORCID: /0000-0003-0016-7591/work/96652713
dc.identifier.otherORCID: /0000-0001-9968-5991/work/96652880
dc.identifier.otherWOS: 85118286176
dc.identifier.otherORCID: /0000-0001-6558-7189/work/103321979
dc.identifier.otherScopus: 85118286176
dc.identifier.otherScopus: 85118286176
dc.identifier.urihttps://hdl.handle.net/2164/17345
dc.descriptionFunding This work was supported by Versus Arthritis [Grant Number: 20748] and the British Society for Rheumatology. The funding for the original studies included were from Versus Arthritis (MAmMOTH) and the British Society for Rheumatology (BSRBR-AS and BSR-PsA). Daniel Whibley is supported by a Versus Arthritis Foundation Fellowship [Grant Number 21742] Acknowledgements We are grateful to help from staff at the National Ankylosing Spondylitis Society and specifically to patient partners Lynne Laidlaw (for help with designing questionnaire) and Susan Davis (for commenting on the manuscript). The authors do not report any conflicts of interest. GJM conceived the idea for the study and all authors were involved in the detailed planning. MH, KK, EM-B and MB were responsible for obtaining ethics and research governance approvals. MB undertook the analysis which was independently verified by GTJ. GJM, with input from MB, drafted the manuscript, and all authors contributed important intellectual content via written comments. We thank Linda Dean for comments on the manuscript. Data Availability Statement The data within the article which relate to the collection of BSR register data are owned by the BSR – access to these data are subject to application being made to the BSR: Registers (rheumatology.org.uk) . For other data in the article, application can be made for access to the data by contacting the corresponding author.en
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.rightsVC The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectCOVID19en
dc.subjectaxial spondyloarthritisen
dc.subjectpsoriatic arthritisen
dc.subjectpainen
dc.subjectquality of lifeen
dc.subjectR Medicineen
dc.subjectArthritis Research UK (ARUK)en
dc.subject20748en
dc.subject21742en
dc.subjectOtheren
dc.subjectBSRBR-ASen
dc.subjectBSR-PsAen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleThe effect of COVID19 public health restrictions on the health of people with musculoskeletal conditions and symptoms : the CONTAIN studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Vice Principalsen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.contributor.institutionUniversity of Aberdeen.Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen.Educationen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1093/rheumatology/keab374


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record